Updated guideline recommendations for HER2 testing

被引：0
作者：
Emad A. Rakha
Ian O. Ellis
机构：
[1] School of Medicine,Division of Oncology
[2] University of Nottingham,undefined
[3] Nottingham City Hospital,undefined
来源：
Nature Reviews Clinical Oncology | 2014年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The recently updated HER2 testing guidelines by ASCO and the College of American Pathologists (CAP) are a significant step towards personalized medicine. It is excellent news that such great effort has been put into standardizing biomarker assessment. Undoubtedly, these recommendations will improve the analytical validity of HER2 testing, its clinical utility and the communication among health-care providers.
引用
收藏
页码：8 / 9
页数：1
相关论文
共 14 条
  • [1] Paik S(2008)HER2 status and benefit from adjuvant trastuzumab in breast cancer N. Engl. J. Med. 358 1409-1411
  • [2] Kim C(2011)Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31 J. Clin. Oncol. 29 3366-3373
  • [3] Wolmark N(2007)American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J. Clin. Oncol. 25 118-145
  • [4] Perez EA(2010)American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J. Clin. Oncol. 28 2784-2795
  • [5] Wolff AC(2009)Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases Arch. Pathol. Lab. Med. 133 775-780
  • [6] Hammond ME(2012)Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast Histopathology 60 880-884
  • [7] Middleton LP(2012)HER2 gene amplification in breast cancer: a rogues' gallery of challenging diagnostic cases: UKNEQAS interpretation guidelines and research recommendations Am. J. Clin. Pathol. 137 595-605
  • [8] Lee AH(2008)Prognostic significance of Nottingham histologic grade in invasive breast carcinoma J. Clin. Oncol. 26 3153-3158
  • [9] Key HP(undefined)undefined undefined undefined undefined-undefined
  • [10] Bell JA(undefined)undefined undefined undefined undefined-undefined
12